Fintel on MSN7h
Piper Sandler Initiates Coverage of Camp4 Therapeutics (CAMP) with Overweight Recommendation
Fintel reports that on November 5, 2024, Piper Sandler initiated coverage of Camp4 Therapeutics (NasdaqGM:CAMP) with a Overweight recommendation. Analyst Price Forecast Suggests 173.74% Upside As of ...
Piper Sandler's Schneider: Fiscal policy will likely drive rates higher in either election outcome
Don Schneider, Piper Sandler deputy head of U.S. policy, joins CNBC's 'The Exchange' to discuss portfolio positioning ahead ...
Piper Sandler Sticks to Their Hold Rating for Dollar Tree (DLTR)
In a report released today, Peter Keith from Piper Sandler maintained a Hold rating on Dollar Tree (DLTR – Research Report), with a price ...